Repigmentation of Hair Following Adalimumab Therapy

January 2015 in “ Dermatology online journal ”

Suzanne J. Tintle, Tushar S. Dabade, Robert A. Kalish, David Rosmarin

adalimumab golimumab tumor necrosis factor inhibitor hair repigmentation rheumatoid arthritis TNF inhibitor

TLDR A patient's grey hair regained color during treatment with adalimumab.

A patient with rheumatoid arthritis (RA) experienced repigmentation of her hair from grey-white to dark brown-black following adalimumab therapy. Despite stable control of her RA and no recent changes in her medical regimen, the patient observed increased pigmentation in her hair, which continued even after switching to golimumab due to increased RA activity. This case was notable as it was the first reported instance of hair repigmentation associated with a tumor necrosis factor (TNF) inhibitor, highlighting a rare side effect of drug-induced changes in hair color.

View this study on escholarship.org →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Hair Repigmentation Associated with the Use of Lenalidomide: Graying May Not Be an Irreversible Process

25 citations, March 2012 in “Journal of oncology pharmacy practice”

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

research Weight Gain and Hair Loss During Anti-TNF Therapy

16 citations, January 2012 in “International Journal of Rheumatology”

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

research Hair Follicle Pigmentation: Mechanisms and Factors Influencing Melanin Production

450 citations, January 2005 in “The journal of investigative dermatology/Journal of investigative dermatology”

Hair color is determined by melanin produced and transferred in hair follicles.

research The Biology of Hair Follicles

1113 citations, August 1999 in “The New England Journal of Medicine”

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Similar Research

5 / 404 results

research Medication-Induced Repigmentation of Gray Hair: A Systematic Review

28 citations, December 2019 in “Skin appendage disorders”

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

research Unmet Medical Needs in Chronic, Non-Communicable Inflammatory Skin Diseases

59 citations, June 2022 in “Frontiers in medicine”

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

research Proceedings of the Ninth World Congress for Hair Research 2015

January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

research Psoriatic Alopecia in a Patient With Crohn's Disease: An Uncommon Manifestation of Tumor Necrosis Factor Alpha Inhibitors

April 2021 in “Cutis”

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

research Randomized Split-Side Study Comparing Efficacy of Botulinum Toxin Type A Versus 0.9% Sodium Chloride in Scalp Psoriasis

January 2018

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.